G17 CANCER RELATED FATIGUE, LEVELS OF HAEMATIC HAEMOGLOBIN AND PRESENCE OF ANXIETY AND DEPRESSION IN HOSPITALISED CANCER PATIENTS F. Romito, F. Giuliani, D. Galetta, M. Di Bisceglie, R. Mallamaci, M. Longo, G. Colucci U.O. Oncologia Medica e Sperimentale, IRCCS Ospedale Oncologico, Bari, Italy Background: Cancer related fatigue is a very common problem among cancer patients, which is not directly connected to illness stage and kind of treatment. It is a multidimensional syndrome, involving both physical and psychological aspects of the patient, which are interrelated and mutually influencing. Fatigue is one of the most common complaints of patients, who are impaired in the pleasant activities of their lives, such as social relationships, hobbies and interests, sex. Anaemia is present in approximately 70% of fatigued patients. Aim: To evaluate levels of cancer related fatigue, in relation with haematic haemoglobin level and the presence of anxiety and depression inhospitalised patients, collecting data regarding kind and stage of treatment. Methods: FACT Scale (Functional Assessment of Cancer Therapy), subscale Anemia, and HAD (Hospital Anxiety and Depression) Questionnaire were administered consecutively to all patients referring to the unit in one week time. Haematic data were collected with routine blood test at the same time of administration of questionnaires. Results: The preliminary sample constituted 23 patients, the majority (15; 65%) were men aged 51(71 years old. Fifty-six percent of patients were receiving the first two chemotherapy treatment cycles. Seven (30%) of these patients show some level of depression (cut-off: 11), whereas nine (39%) are anxious (cut-off: 8). Anxiety and depression co-occur in five patients (22%), depression alone in 17%, only anxiety in 9%. The last data could be interpreted in the light of our experience with clinicians who are more likely to detect the presence of anxiety in cancer patients. Fatigue is present in 30% of patients, one with no anxiety nor depression, the remaining equally divided in half with co-occurring depression and anxiety, and half who are only depressed. Patients who are only anxious show low level of fatigue in this sample. Haematic data are still not available.

Cancer related fatigue, levels of haematic haemoglobin and presence of anxiety and depression in hospitalised cancer patients

MALLAMACI, Rosanna;
2005

Abstract

G17 CANCER RELATED FATIGUE, LEVELS OF HAEMATIC HAEMOGLOBIN AND PRESENCE OF ANXIETY AND DEPRESSION IN HOSPITALISED CANCER PATIENTS F. Romito, F. Giuliani, D. Galetta, M. Di Bisceglie, R. Mallamaci, M. Longo, G. Colucci U.O. Oncologia Medica e Sperimentale, IRCCS Ospedale Oncologico, Bari, Italy Background: Cancer related fatigue is a very common problem among cancer patients, which is not directly connected to illness stage and kind of treatment. It is a multidimensional syndrome, involving both physical and psychological aspects of the patient, which are interrelated and mutually influencing. Fatigue is one of the most common complaints of patients, who are impaired in the pleasant activities of their lives, such as social relationships, hobbies and interests, sex. Anaemia is present in approximately 70% of fatigued patients. Aim: To evaluate levels of cancer related fatigue, in relation with haematic haemoglobin level and the presence of anxiety and depression inhospitalised patients, collecting data regarding kind and stage of treatment. Methods: FACT Scale (Functional Assessment of Cancer Therapy), subscale Anemia, and HAD (Hospital Anxiety and Depression) Questionnaire were administered consecutively to all patients referring to the unit in one week time. Haematic data were collected with routine blood test at the same time of administration of questionnaires. Results: The preliminary sample constituted 23 patients, the majority (15; 65%) were men aged 51(71 years old. Fifty-six percent of patients were receiving the first two chemotherapy treatment cycles. Seven (30%) of these patients show some level of depression (cut-off: 11), whereas nine (39%) are anxious (cut-off: 8). Anxiety and depression co-occur in five patients (22%), depression alone in 17%, only anxiety in 9%. The last data could be interpreted in the light of our experience with clinicians who are more likely to detect the presence of anxiety in cancer patients. Fatigue is present in 30% of patients, one with no anxiety nor depression, the remaining equally divided in half with co-occurring depression and anxiety, and half who are only depressed. Patients who are only anxious show low level of fatigue in this sample. Haematic data are still not available.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11586/102546
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact